Skip to main content

Advertisement

SpringerLink
Log in

Neurocysticercosis: Current knowledge and advances

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Neurocysticercosis is the most common cause of acquired seizures worldwide. Most cases of this larval stage infection of the pork tapeworm Taenia solium occur in the developing world, although increasing numbers of cases are being recognized in the United States, particularly among Hispanic immigrants. The ability of the pathogen to persist for years within the host is the subject of immunologic and biochemical investigation. The major presenting symptom is seizures, although symptoms of obstructive hydrocephalus occur if cysts are located near the ventricles or in the subarachnoid spaces. Diagnosis is dependent on clinical, radiologic, and serologic data. Therapy with antiparasitic agents, especially albendazole, is effective in large burden disease or disease within sensitive neuraxis sites (the ventricles, the subarachnoid spaces). When patients with radiologically enhancing disease are given cysticidal therapy, there appears to be a reduction in seizure recurrences. Surgery is indicated for disease in selected anatomic sites. Longterm prevention requires attention to pork husbandry and general sanitation, including the potential use of mass human chemotherapy and porcine vaccination.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Beaver PC, Jung RC, Wayne E: Cyclophyllidean tapeworms, In Clinical Parasitology, edn 9. Philadelphia: Lea and Febiger; 1984:513.

    Google Scholar 

  2. MacArthur WP: Cysticercosis as seen in the British army, with special reference to the production of epilepsy. Transaction R Soc Trop Med Hyg 1934, 27:343–357.

    Article  Google Scholar 

  3. Richards FO Jr, Schantz PM, Ruiz-Tiben E, Sorvillo FJ: Cysticercosis in Los Angeles County. JAMA 1985, 254:3444–3448.

    Article  PubMed  Google Scholar 

  4. Shandera WX, White AC Jr, Chen JC, et al.: Neurocysticercosis in Houston, Texas. A report of 112 cases. Medicine (Baltimore) 1994, 73:37–52.

    CAS  Google Scholar 

  5. Sorvillo FJ, Waterman SH, Richards FO, Schantz PM: Cysticercosis surveillance: locally acquired and travel-related infections and detection of intestinal tapeworm carriers in Los Angeles County. Am J Trop Med Hyg 1992, 47:365–371.

    PubMed  CAS  Google Scholar 

  6. Garcia-Garcia ML, Torres M, Correa D, et al.: Prevalence and risk of cysticercosis and taeniasis in an urban population of soldiers and their relatives. Am J Trop Med Hyg 1999, 61:386–389.

    PubMed  CAS  Google Scholar 

  7. Garcĺa HH, Gilman RH, Gonzales AE: Epidemiologia de la cysticercosis en el Perú. In Taeniasis/Cisticercosis por T. solium. Edited by Garcĺa HH, Martinez SM. Lima, Peru: Editorial Universo SA; 1984:313–326.

    Google Scholar 

  8. Schantz PM: Taenia solium cysticercosis: an overview of global distribution and transmission. In Taenia solium Cysticercosis; from Basic to Clinical Science. Edited by Singh G, Prabhakar S. Wallingford Oxon, United Kingdom: CABI Publishing; 2002:63–73.

    Google Scholar 

  9. Singh G, Prabhakar S: Taenia solium Cysticercosis; from Basic to Clinical Science. Wallingford Oxon, United Kingdom: CABI Publishing; 2002.

    Google Scholar 

  10. Garcia HH, Gilman RH, Gonzalez AE, et al.: What have we learnt from epidemiological studies of Taenia solium cysticercosis in Peru? In Taenia solium Cysticercosis; from Basic to Clinical Science. Edited by Singh G, Prabhakar S. Wallingford Oxon, United Kingdom: CABI Publishing; 2002:76–78.

    Google Scholar 

  11. Sarti E: Epidemiology of Taenia solium taeniasis and cysticercosis in Mexico. In Taenia solium Cysticercosis; from Basic to Clinical Science. Edited by Singh G, Prabhakar S. Wallingford Oxon, United Kingdom: CABI Publishing; 2002:87.

    Google Scholar 

  12. Garcia-Noval J, Sanchez AL, Allan JC: Taenia solium taeniasis and cysticercosis in Central America. In Taenia solium Cysticercosis; from Basic to Clinical Science. Edited by Singh G, Prabhakar S. Wallingford Oxon, United Kingdom: CABI Publishing; 2002:94–95.

    Google Scholar 

  13. Fan PC, Chung WC, Soh CT, et al.: Eating habits of East Asian people and transmission of taeniasis. Acta Tropica 1992, 50:305–315.

    Article  PubMed  CAS  Google Scholar 

  14. Hira PR, Francis I, Abdella NA, Gupta R, et al.: Cysticercosis: imported and autochthonous infections in Kuwait. Trans R Soc Trop Med Hyg 2004, 98:233–239.

    Article  PubMed  Google Scholar 

  15. Schantz PM, Moore AC, Muñoz JL, et al.: Neurocysticercosis in an Orthodox Jewish community in New York City. N Engl J Med 1992, 327:692–695.

    Article  PubMed  CAS  Google Scholar 

  16. Restrepo BI, Aguilar MI, Melby PC, Teale JM: Analysis of the peripheral immune response in patients with neurocysticercosis: evidence for T cell reactivity to parasite glycoprotein and vesicular fluid antigens. Am J Trop Med Hyg 2001, 65:366–370.

    PubMed  CAS  Google Scholar 

  17. Meza-Lucas A, Carmona-Miranda L, Garcia-Jeronimo RC, et al.: Short report: limited and short-lasting humoral response in Taenia solium: seropositive households compared with patients with neurocysticercosis. Am J Trop Med Hyg 2003, 69:223–227.

    PubMed  Google Scholar 

  18. Garcia HH, Gonzalez AE, Gilman RH, et al.: Cysticercosis Working Group in Peru: Short report: transient antibody response in Taenia solium infection in field conditions—a major contributor to high seroprevalence. Am J Trop Med Hyg 2001, 65:31–32.

    PubMed  CAS  Google Scholar 

  19. Flisser A, Correa A, Evans CA: Taenia solium cysticercosis: new and revisited immunological aspects. In Taenia solium Cysticercosis; from Basic to Clinical Science. Edited by Singh G, Prabhakar S. Wallingford Oxon, United Kingdom: CABI Publishing; 2002:16.

    Google Scholar 

  20. Grewal JS, Kaur S, Bhatti G, et al.: Cellular immune responses in human neurocysticercosis. Parasitol Res 2000, 86:500–503.

    Article  PubMed  CAS  Google Scholar 

  21. Robinson P, Altamar R, Lewis D, et al.: Brain granulomas in murine cysticercosis. Infect Immun 1997, 89:64–72.

    Google Scholar 

  22. Robinson P, White AC, Lewis DE, et al.: Sequential expression of the neuropeptides substance P and somatostatin in granulomas associated with murine cysticercosis. Infect Immun 2002, 70:4534–4538.

    Article  PubMed  CAS  Google Scholar 

  23. Restrepo BI, Alvarez JI, Castano JA, et al.: Brain granulomas in neurocysticercosis patients are associated with a Th1 and Th2 profile. Infect Immunol 2001, 69:4554–4560.

    Article  CAS  Google Scholar 

  24. Mlinari JL, Tato P: Molecular determinants of host-parasite interactions: focus on parasite. In Taenia solium Cysticercosis; from Basic to Clinical Science. Edited by Singh G, Prabhakar S. Wallingford Oxon, United Kingdom: CABI Publishing; 2002:28–32.

    Google Scholar 

  25. Padma V, Jain S, Srivastava A, et al.: Hereditary factors in neurocysticercosis with emphasis on single, small enhancing CT lesions. In Taenia solium Cysticercosis; from Basic to Clinical Science. Edited by Singh G, Prabhakar S. Wallingford Oxon, United Kingdom: CABI Publishing; 2002:58–59.

    Google Scholar 

  26. Del Brutto OH, Granados G, Talamas O, et al.: Genetic pattern of the HLA system: HLA A, B, C, DR, and DQ antigens in Mexican patients with parenchymal brain cysticercosis. Hum Biol 1991, 63:85–93.

    Google Scholar 

  27. Garcia HH, Del Brutto OH, Nash TE, et al.: New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). Am J Trop Med Hyg 2005, 72:3–9.

    PubMed  Google Scholar 

  28. Garcia HH, Del Brutto OH, for the Cysticercosis Working Group in Peru: Neurocysticercosis: updated concepts about an old disease. Lancet Neurol 2005, 4:653–661.

    Article  PubMed  Google Scholar 

  29. Del Brutto OH: Neurocysticercosis. Sem Neurol 2005, 25:243–251.

    Article  Google Scholar 

  30. Del Brutto OH, Santibanez, CA, Noboa CA, et al.: Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 1992, 42:389–392.

    PubMed  Google Scholar 

  31. Carpio A, Hauser WA: Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology 2002, 59:1730–1734.

    PubMed  Google Scholar 

  32. Nash TE, Del Brutto OH, Butman JA, et al.: Calcific neurocysticercosis and epileptogenesis. Neurology 2004, 62:1934–1938.

    PubMed  CAS  Google Scholar 

  33. Do Amaral LL, Ferreira RM, da Rocha AJ, et al.: Neurocysticercosis: evaluation with advanced magnetic resonance techniques and atypical forms. Top Magn Reson Imaging 2005, 16:127–144.

    Article  Google Scholar 

  34. Torres-Corzo, J, Rodriguez-della Vecchia R, Rangel-Castilla L: Bruns syndrome caused by intraventricular neurocysticercosis treated using flexible endoscopy. J Neurosurg 2006, 104:746–748.

    PubMed  Google Scholar 

  35. Takayanagui OM, Odashima NS: Clinical aspects of neurocysticercosis. Parasitol Int 2006, 55:S111-S115.

    Article  PubMed  Google Scholar 

  36. Ramirez-Bermudez J, Higuera J, Sosa AL, et al.: Is dementia reversible in patients with neurocysticercosis? J Neurol Neurosurg Psychiatry 2005, 76:1164–1166.

    Article  PubMed  CAS  Google Scholar 

  37. Ito A, Nakao M, Okamoto M, et al.: Mitochondrial DNA of Taenia solium: from basic to applied science. In Taenia solium Cysticercosis; from Basic to Clinical Science. Edited by Singh G, Prabhakar S. Wallingford Oxon, United Kingdom: CABI Publishing; 2002:51.

    Google Scholar 

  38. Nash TE, Neva FA: Recent advances in the diagnosis and treatment of cerebral cysticercosis. N Engl J Med 1984, 311:1492–1496.

    Article  PubMed  CAS  Google Scholar 

  39. Dua T, Aneja S: Neurocysticercosis: management issues. Indian Pediatr 2006, 42:227–235.

    Google Scholar 

  40. Proano-Narvaez JV, Meza-Lucas A, Mata-Ruiz O, et al.: Laboratory diagnosis of human neurocysticercosis: doubleblind comparison of enzyme-linked immunosorbent assay and electroimmunotransfer blot assay. J Clin Microbiol 2002, 40:2115–2118.

    Article  PubMed  CAS  Google Scholar 

  41. Garcia HH, Evans CA, Nash TE, et al.: Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 2002, 15:747–756.

    Article  PubMed  Google Scholar 

  42. Riley T, White AC Jr: Management of neurocysticercosis. CNS Drugs 2003, 17:577–591.

    Article  PubMed  CAS  Google Scholar 

  43. Del Brutto OH, Roos KL, Coffey CS, Garcia HH: Meta-analysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med 2006, 145:43–51.

    Google Scholar 

  44. Takayanagui OM: Therapy for neurocysticercosis: Expert Rev Neurotherapeutics 2004, 4:129–139.

    Article  CAS  Google Scholar 

  45. Garcia HH, Pretell EJ, Gilman RH, et al.: A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cyticercosis. N Eng J Med 2004, 350:249–258. Important reference.

    Article  CAS  Google Scholar 

  46. Singhi P, Dayal D, Khandelwal N: One week versus four weeks of albendazole therapy for neurocysticercosis in children: a randomized, placebo-controlled double blind trial. Pediatr Infect Dis J 2003, 22:268–272.

    Article  PubMed  Google Scholar 

  47. Gongora-Rivera F, Soto-Hernandez JL, Gonzalez Esquivel MS, et al.: Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis. Neurology 2006, 66:436–438.

    Article  PubMed  CAS  Google Scholar 

  48. Allan JC, Craig PS, Pawlowski ZS: Control of Taenia solium with emphasis on treatment of taeniasis. In Taenia solium Cysticercosis; from Basic to Clinical Science. Edited by Singh G, Prabhakar S. Wallingford Oxon United Kingdom: CABI Publishing; 2002:416–417.

    Google Scholar 

  49. Gonzalez AE, Gilman RH, Garcia HH, Lopez T: Use of a simulation model to evaluate control programmes against Taenia solium cysticercosis. In Taenia solium cysticercosis; from Basic to Clinical Science. Edited by Singh G, Prabhakar S. Wallingford Oxon, United Kingdom: CABI Publishing; 2002:444.

    Google Scholar 

  50. Gonzalez AE, Gauci CG, Barber D, et al.: Vaccination of pigs to control human neurocysticercosis. Am J Trop Med Hyg 2005, 72:837–839.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Section of General Medicine 2RM-81-001, 1504 Taub Loop, 77030, Houston, TX, USA

    Wayne X. Shandera MD

Authors
  1. Wayne X. Shandera MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joseph S. Kass MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wayne X. Shandera MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shandera, W.X., Kass, J.S. Neurocysticercosis: Current knowledge and advances. Curr Neurol Neurosci Rep 6, 453–459 (2006). https://doi.org/10.1007/s11910-006-0046-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-006-0046-3

Keywords

Search

Navigation